BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

SpePharm 

Kingsfordweg 151

Amsterdam    1043 GR  The Netherlands
Phone: 31-0-20-4919602 Fax: 31-0-20-4919090


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Clinigen Group Acquires Oncology Support Therapy SAVENE® (Dexrazoxane) From SpePharm 3/31/2014 8:26:05 AM    More...
SpePharm Sells Japanese Rights for Savene(R) to Kissei Pharmaceutical Co., Ltd. 9/1/2011 10:08:01 AM    More...
BioAlliance Pharma Filed an Appeal to the French Supreme Court Contesting a Preliminary Procedural Decision on Jurisdiction in the Arbitration Against SpePharm and SpeBio 6/1/2011 12:53:45 PM    More...
The Paris Court Of Appeals Rejects the Appeals Lodged by BioAlliance Pharma In A Case Against SpePharm and Spebio BV, And Orders Bioalliance Pharma to Refund in Total €500K Of Legal Costs to the Two Companies 5/31/2011 2:40:03 PM    More...
SpePharm Announces the Acquisition of Savene(R) from TopoTarget A/S; 11 Million Euros New Round of Financing, and a Strategic Partnership with Paladin Labs Inc. (CC:PLB) 3/4/2010 6:55:53 AM    More...
Access Pharmaceuticals (ACCP) Announces Commercial Launch of MuGard(TM) in Norway by SpePharm 7/27/2009 9:05:01 AM    More...
Access Pharmaceuticals (ACCP) Announces Commercial Launch of MuGard(TM) in Greece by SpePharm 6/30/2009 8:25:36 AM    More...
Access Pharmaceuticals (ACCP) Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 4/22/2009 8:50:33 AM    More...
SpePharm Announces the European Launches of Two New Products: MuGard(R) and Xerotin(R) 4/20/2009 10:08:12 AM    More...
SpePharm Announces a Claim in Excess of 35 Million Euros Against BioAlliance Pharma For Breaking up Their Joint-Venture 4/14/2009 6:57:48 AM    More...
12

//-->